Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
6-week randomized double-blind placebo-controlled study of lurasidone in acutely psychotic subjects with schizophrenia
jRCT2080223187Phase 3Completed
- Sponsor
- Sunovion
- Start
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in schizophrenia comparing Lurasidone 40 mg/day with Placebo (2 arms). Started Apr 2016; status: completed.
02
Drugs
lurasidone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on jRCT2080223187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223187.